Studies have linked APOE ε4 to increased risk and lower age of onset of frontotemporal dementia (FTD)2–6, Parkinson’s disease (PD)5,7,8 and amyotrophic lateral sclerosis (ALS)9,10. Here, APOE is linked to Parkinson disease.